Notice of NCI's Withdrawal from Participation in PAR-19-064, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"
Notice Number:
NOT-CA-21-014

Key Dates

Release Date:

November 10, 2020

Related Announcements

NOT-CA-19-015 - Notice of NCI Participation in PAR-19-064, Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)

PAR-19-064 - Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

This Notice informs potential applicants that, effective immediately, the National Cancer Institute (NCI) will no longer be participating in PAR-19-064, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)" and will not accept applications to PAR-19-064.

The following changes have been made to reflect NCI's withdrawal from the PAR-19-064.


I. Part 1. Overview Information

Currently Reads

Components of Participating Organizations:

National Institute on Drug Abuse (NIDA)
National Cancer Institute (NCI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)


Catalog of Federal Domestic Assistance (CFDA) Numbers:
93.279
93.399
93.273

Modified to Read

Components of Participating Organizations:

National Institute on Drug Abuse (NIDA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Catalog of Federal Domestic Assistance (CFDA) Numbers:
93.279
93.273

II. Part 2. Full Text of Announcement, Section VII. Agency Contacts

Currently Reads

Scientific/Research Contact(s)

Kelly D. Blake, Sc.D.
National Cancer Institute
Telephone: 240-281-5934
Email: [email protected]

Marsha F. Lopez, PhD, MHS
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504
Email: [email protected])

Gregory Bloss, M.A., M.P.P.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-3865
Email: [email protected]

Financial/Grants Management Contact(s)

Crystal Wolfrey
National Cancer Institute
Telephone: 240-276-6277
Email: [email protected]

Jennifer Schermerhorn
National Institute on Drug Abuse (NIDA)
Telephone: 301-451-2649
Email: [email protected]

Judy Fox
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-4704
Email:[email protected]

Modified to Read

Scientific/Research Contact(s)

Marsha F. Lopez, PhD, MHS
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504
Email: [email protected])

Gregory Bloss, M.A., M.P.P.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-3865
Email: [email protected]

Financial/Grants Management Contact(s)

Jennifer Schermerhorn
National Institute on Drug Abuse (NIDA)
Telephone: 301-451-2649
Email: [email protected]

Judy Fox
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-4704
Email:[email protected]

Inquiries

Please direct all inquiries to:

Please direct all inquiries to:

Kelly D. Blake, Sc.D.
National Cancer Institute (NCI)
Telephone: 240-281-5934
Email: [email protected]


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices